REVIR THERAPEUTICS (HK) LIMITED

ReviR Therapeutics is a global, clinical-stage biotechnology company committed to discovering and developing innovative RNA-targeting small-molecule therapies for neurological diseases, inflammation and immunology (I&I) and oncology. ReviR was founded in 2021 by leaders in computational biology, RNA biology, genomics and drug discovery, with the aim of creating highly selective, effective and safe disease-modifying therapies. Its proprietary VoyageR™ platform integrates AI-enabled modelling, RNA